ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000270062.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.038890381	Sensitive
ENSG00000270062.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.011223332	Sensitive